X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Connect 2 Cleanrooms and RoslinCT partner to introduce new GMP Cell and Gene Therapy Facility

Content Team by Content Team
22nd October 2021
in News
Connect 2 Cleanrooms and RoslinCT partner to introduce new GMP Cell and Gene Therapy Facility

Connect 2 Cleanrooms (C2C), in partnership with RoslinCT, is pleased to present the new state-of-the-art GMP manufacturing facility and training laboratory at RoslinCT’s BioCube building in Edinburgh’s BioQuarter.

RoslinCT is a cell therapy Contract Development and Manufacturing Organisation (CDMO) working on developing cell and gene therapy research into robust GMP-qualified processes, enabling its clients to bring therapies safely to the patient. GMP (Good Manufacturing Practice) is a system designed to ensure pharmaceutical products are created according to the highest quality standards. The new 1600m² GMP cell and gene therapy manufacturing facility will be used to develop life-changing, next-generation treatments for patients throughout the world.

As a cleanroom design and build specialist, C2C was appointed as Principal Contractor by RoslinCT at the end of 2019 with work commencing on-site in early 2020. In addition to the facility build, C2C provided an end-to-end service with an integrated supply of consumables, equipment, and validation.

The existing 2-storey BioCube building housed office and laboratory spaces. RoslinCT’s first stage expansion plan suggested alterations and fit-outs to create a modern 33-room manufacturing facility, with five cleanrooms at its heart. The planning and installation process was fully project managed by Connect 2 Cleanrooms at every stage—from the initial CAD drawings to completion.

C2C’s cleanroom design achieves space efficiency by using the latest decentralised air-handling technology. C2C created a Computational Fluid Dynamic study to plot airflow throughout the building and used 3D point cloud surveys to plan HVAC ducting, gas lines, interlocks, and raceways. Through this innovative planning of services, office premises were retained in the new facility for RoslinCT.

The decentralised air handling design not only saves space but also enables RoslinCT to perform maintenance in individual rooms without requiring full facility closure. Along with 24/7 controlled systems and a permanent generator, this allows flexibility and continuity for RoslinCT’s innovative cell and gene therapy offering.

Other noteworthy features of the cleanroom complex at RoslinCT include Vapourised Hydrogen Peroxide (VHP) hatches—for the full kill of microorganisms during materials transfer— and a 21 CFR 11 Environmental Monitoring System that continuously audits the environment to prove GMP-compliancy.

GMP guidelines were followed during the construction of the new facility to endure all relevant validation and commissioning protocols met regulatory requirements. The facility operates to US and EU GMP standards and ensures the highest standards for the end product.

Previous Post

WAPG and Astellas Announce Future Innovator Prize to Help Emerging Biotechs Accelerate Early Drug Discovery and Research Efforts

Next Post

Ubiquigent Extends and Expands Drug Discovery Collaboration With Bristol Myers Squibb

Related Posts

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Drugs Gain From Tardigrade Proteins, Says Research
Drug Development

Pharma Drugs Gain From Tardigrade Proteins, Says Research

22nd March 2023
Next Post
Ubiquigent Extends and Expands Drug Discovery Collaboration With Bristol Myers Squibb

Ubiquigent Extends and Expands Drug Discovery Collaboration With Bristol Myers Squibb

Latest News

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In